Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527105 | SCV000625038 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001009823 | SCV001169937 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001009823 | SCV002051934 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-12 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003708 | SCV004840947 | likely benign | Lynch syndrome | 2023-05-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248109 | SCV005895964 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2024-11-21 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |